Learn more about innovative treatments that have been funded through the Prostate Cancer Research Program (PCRP), part of the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense.
The Prostate Cancer Research Program (PCRP), part of the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense, is one of the most effective programs in the world designed to produce treatments and, one day, a cure for prostate cancer. Groundbreaking Prostate Cancer Treatments Deliver Hope
An AR-targeted therapy indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer. JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing treatment regimen.
Identifies whether your tumor will respond to AR-targeted therapies—or whether you should consider chemotherapy or other therapies.
RUBRACA ® tablets are a prescription medicine used in adults for the treatment of castration-resistant prostate cancer (prostate cancer that no longer responds to medical or surgical treatment that lowers testosterone).
XGEVA ® is used for prostate cancer patients with metastatic bone disease to prevent fractures, severe bone pain, and spinal cord compression.
The Xofigo ® (radium Ra 223 dichloride) injection is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone. It is for men whose prostate cancer has spread to the bone with symptoms but not to other parts of the body. A prescription medicine used to treat prostate cancer that no longer responds to a hormone therapy or surgical treatment to lower testosterone OR has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone.
ZYTIGA ® is a prescription medicine that is used along with prednisone. ZYTIGA ® is used to treat men with prostate cancer that has spread to other parts of the body.
Tell your elected officials that you want increased funding for the PCRP to generate more new treatment options for prostate cancer patients. Visit zerocancer.org/advocacy t o get started today.
Page 1Made with FlippingBook flipbook maker